• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年精神病患者的躯体共病与多重用药

Physical comorbidity and polypharmacy in older psychiatric patients.

作者信息

Lacro J P, Jeste D V

机构信息

Department of Psychiatry, University of California, San Diego.

出版信息

Biol Psychiatry. 1994 Aug 1;36(3):146-52. doi: 10.1016/0006-3223(94)91220-3.

DOI:10.1016/0006-3223(94)91220-3
PMID:7948452
Abstract

We compared three groups of older psychiatric outpatients on numbers and types of physical illnesses and on number of nonpsychotropic medications. The subjects included 62 patients with Alzheimer's disease (AD), 41 with major depression (MD), and 78 with schizophrenia (SZ). The mean age in this predominantly male population was 68.4 years. Psychiatric diagnoses were based on DSM-III-R criteria. We utilized intake psychiatric assessments, chart reviews, and computerized pharmacy profiles to collect the data. The patients with SZ had significantly lower comorbidity compared to patients with MD, and had a significantly lower number of nonpsychotropic medications prescribed than both the AD and MD groups. These findings may reflect biological differences or may be secondary to differences in psychiatric treatment or in the use of health care resources. Alternatively, the low prevalence of physical comorbidity in SZ may represent a survivor or healthier cohort of patients.

摘要

我们比较了三组老年精神科门诊患者的躯体疾病数量及类型,以及非精神类药物的使用数量。研究对象包括62例阿尔茨海默病(AD)患者、41例重度抑郁症(MD)患者和78例精神分裂症(SZ)患者。在这个以男性为主的人群中,平均年龄为68.4岁。精神疾病诊断依据《精神疾病诊断与统计手册》第三版修订版(DSM-III-R)标准。我们通过入院时的精神科评估、病历审查和电脑化药房记录来收集数据。与MD患者相比,SZ患者的合并症显著更少,且开具的非精神类药物数量明显低于AD组和MD组。这些发现可能反映了生物学差异,也可能是精神科治疗差异或医疗资源使用差异的继发结果。或者,SZ患者躯体合并症的低患病率可能代表了存活下来的患者或健康状况更佳的患者群体。

相似文献

1
Physical comorbidity and polypharmacy in older psychiatric patients.老年精神病患者的躯体共病与多重用药
Biol Psychiatry. 1994 Aug 1;36(3):146-52. doi: 10.1016/0006-3223(94)91220-3.
2
Psychiatric-medical comorbidity: implications for health services delivery and for research on depression.精神科与内科的共病现象:对医疗服务提供及抑郁症研究的影响
Biol Psychiatry. 1994 Aug 1;36(3):141-5. doi: 10.1016/0006-3223(94)91219-x.
3
Among the elderly, many mental illnesses go undiagnosed.在老年人中,许多精神疾病未被诊断出来。
Health Aff (Millwood). 2015 May;34(5):727-31. doi: 10.1377/hlthaff.2015.0314.
4
[Psychiatric disorders in the elderly and psychosocial background. A study of geriatric inpatients].[老年人的精神障碍与社会心理背景。一项对老年住院患者的研究]
Psychiatr Prax. 1999 Nov;26(6):267-72.
5
Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.万塔抑郁症研究中接受精神科护理的DSM-IV重度抑郁症患者当前的精神疾病共病情况。
J Clin Psychiatry. 2002 Feb;63(2):126-34.
6
Clinical characteristics and length of hospital stay among older adults with bipolar disorder, schizophrenia or schizoaffective disorder, depression, and dementia.双相情感障碍、精神分裂症或分裂情感性障碍、抑郁症和痴呆症老年患者的临床特征及住院时间
J Geriatr Psychiatry Neurol. 2004 Mar;17(1):3-8. doi: 10.1177/0891988703258821.
7
The construct of minor and major depression in Alzheimer's disease.阿尔茨海默病中轻度和重度抑郁的结构
Am J Psychiatry. 2005 Nov;162(11):2086-93. doi: 10.1176/appi.ajp.162.11.2086.
8
Psychoses in the elderly: a spectrum of disorders.老年人的精神病:一系列疾病
J Clin Psychiatry. 1999;60 Suppl 8:4-10.
9
[Prevalence of psychiatric disorders in elderly inpatients of medical and surgical departments].[内科与外科老年住院患者精神障碍的患病率]
Psychiatr Prax. 2000 May;27(4):170-5.
10
Comorbidity in psychosis at first hospitalization.首次住院时精神病的共病情况。
Am J Psychiatry. 1993 May;150(5):752-7. doi: 10.1176/ajp.150.5.752.

引用本文的文献

1
Quantitative and economic analysis of clinical pharmacist interventions during rounds in an acute care psychiatric hospital.急性护理精神病医院查房期间临床药师干预的定量与经济分析。
Ment Health Clin. 2016 Aug 31;6(5):242-247. doi: 10.9740/mhc.2016.09.242. eCollection 2016 Sep.
2
A tipping point in drug dosing in late-life schizophrenia.老年精神分裂症药物剂量的转折点。
Curr Psychiatry Rep. 2011 Jun;13(3):225-33. doi: 10.1007/s11920-011-0189-z.
3
Relative tolerability of Alzheimer's disease treatments.阿尔茨海默病治疗的相对耐受性
Psychiatry (Edgmont). 2008 Nov;5(11):27-36.
4
Bone mass in schizophrenia and normal populations across different decades of life.精神分裂症患者与正常人群在不同年龄段的骨量情况。
BMC Musculoskelet Disord. 2009 Jan 1;10:1. doi: 10.1186/1471-2474-10-1.
5
Healthcare costs and utilization for Medicare beneficiaries with Alzheimer's.患有阿尔茨海默病的医疗保险受益人的医疗保健成本和利用率。
BMC Health Serv Res. 2008 May 22;8:108. doi: 10.1186/1472-6963-8-108.
6
Patient-oriented strategies for the prevention of drug interactions.以患者为导向的药物相互作用预防策略。
Drug Saf. 2000 Feb;22(2):103-9. doi: 10.2165/00002018-200022020-00003.
7
Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI.迟发性轻度和重度抑郁症:使用MRI检测到的常见神经解剖学基础的早期证据。
Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7654-8. doi: 10.1073/pnas.95.13.7654.
8
Geriatric psychosis.老年期精神病
Psychiatr Q. 1997 Fall;68(3):247-60. doi: 10.1023/a:1025436207315.